Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-0714 in healthy subjects
NCT02639078Phase 1Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Nov 2015
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TD-0714 in heart failure (HF), sponsored by Theravance Biopharma, Inc. Primary endpoint: Safety and tolerability of TD-0714. Started Nov 2015; status: completed.
02
Drugs
TD-0714
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02639078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639078.